Recent research points to higher levels of Ng specifically in those with MCI and dementia due to AD who are also APOE ε4 carriers compared to those without ε4 [14, 24, 25], suggesting an influence of APOE in determining Ng levels in the early stages of AD. The gene discussed is NRGN; the disease is Alzheimer disease.